SRXH Stock — SRX Health Solutions, Inc.

SRX Health Solutions, Inc. (SRXH)

Updated October 16, 2026.

SRXH is a Stock. its trailing-12-month yield is 4.20%. Its deepest 1-year drawdown was 96.5%.

SRX Global Inc. operates an AI-driven investment platform focused on identifying and managing stakes in high-conviction operating companies and technology-enabled opportunities across various sectors, leveraging proprietary technology and data analytics to drive long-term shareholder value. The company does not maintain a regular distribution schedule. The company's distribution history includes special or one-time payouts that may not recur regularly.

SRXH performance

Returns are updating. SRXH's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 96.5%.

SRXH key facts

Asset type

Stock

Asset class

Equity

Distribution frequency

None

Trailing yield

4.20%

Last close

$1.19 (as of 2026-10-16)

Market cap

$24,019,425

Average volume

346726.0

Dividend

$0.05

Ex-dividend date

07/22/2026

Payment date

08/03/2026

Payout ratio

0.0%

P/E ratio

0.02

EPS

$62.19

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (4.20%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

SRXH risks and drawbacks

The deepest 1-year drawdown on record here is 96.5%.

Who may consider SRXH — and who may not

It is a weaker fit for investors who need monthly cash flow (SRXH does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on SRXH

• All tickers starting with S

Tagged: Healthcare.

Frequently asked questions